These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 32217663)

  • 21. Primary lateral sclerosis: a distinct entity or part of the ALS spectrum?
    Finegan E; Chipika RH; Shing SLH; Hardiman O; Bede P
    Amyotroph Lateral Scler Frontotemporal Degener; 2019 May; 20(3-4):133-145. PubMed ID: 30654671
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Amyotrophic lateral sclerosis and primary lateral sclerosis: The role of diffusion tensor imaging and other advanced MR-based techniques as objective upper motor neuron markers.
    Wang S; Melhem ER
    Ann N Y Acad Sci; 2005 Dec; 1064():61-77. PubMed ID: 16394148
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Guidelines in motor neurone disease (MND)/amyotrophic lateral sclerosis (ALS) - from diagnosis to patient care.
    Mitchell JD
    J Neurol; 2000 Dec; 247 Suppl 6():VI/7-12. PubMed ID: 19714406
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical features that distinguish PLS, upper motor neuron-dominant ALS, and typical ALS.
    Gordon PH; Cheng B; Katz IB; Mitsumoto H; Rowland LP
    Neurology; 2009 Jun; 72(22):1948-52. PubMed ID: 19487653
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Primary lateral sclerosis: upper-motor-predominant amyotrophic lateral sclerosis with frontotemporal lobar degeneration--immunohistochemical and biochemical analyses of TDP-43.
    Kosaka T; Fu YJ; Shiga A; Ishidaira H; Tan CF; Tani T; Koike R; Onodera O; Nishizawa M; Kakita A; Takahashi H
    Neuropathology; 2012 Aug; 32(4):373-84. PubMed ID: 22098653
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Primary lateral sclerosis as a phenotypic manifestation of familial ALS.
    Brugman F; Wokke JH; Vianney de Jong JM; Franssen H; Faber CG; Van den Berg LH
    Neurology; 2005 May; 64(10):1778-9. PubMed ID: 15911810
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Familial clustering of primary lateral sclerosis and amyotrophic lateral sclerosis: Supplementary evidence for a continuum.
    Corcia P; Lunetta C; Couratier P; Vourc'h P; Gromicho M; Desnuelle C; Soriani MH; Pinto S; de Carvalho M
    Eur J Neurol; 2021 Aug; 28(8):2780-2783. PubMed ID: 34110677
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Guidelines in motor neurone disease (MND)/amyotrophic lateral sclerosis (ALS)--from diagnosis to patient care.
    Mitchell JD
    J Neurol; 2000 Dec; 247():7-12. PubMed ID: 11200703
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cerebellar tract alterations in PLS and ALS.
    Tu S; Menke RAL; Talbot K; Kiernan MC; Turner MR
    Amyotroph Lateral Scler Frontotemporal Degener; 2019 May; 20(3-4):281-284. PubMed ID: 30663900
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Primary lateral sclerosis.
    Singer MA; Statland JM; Wolfe GI; Barohn RJ
    Muscle Nerve; 2007 Mar; 35(3):291-302. PubMed ID: 17212349
    [TBL] [Abstract][Full Text] [Related]  

  • 31. TDP-43 in differential diagnosis of motor neuron disorders.
    Dickson DW; Josephs KA; Amador-Ortiz C
    Acta Neuropathol; 2007 Jul; 114(1):71-9. PubMed ID: 17569066
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diffusion tensor imaging and quantitative susceptibility mapping as diagnostic tools for motor neuron disorders.
    Weidman EK; Schweitzer AD; Niogi SN; Brady EJ; Starikov A; Askin G; Shahbazi M; Wang Y; Lange D; Tsiouris AJ
    Clin Imaging; 2019; 53():6-11. PubMed ID: 30286313
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Amyotrophic lateral sclerosis and primary lateral sclerosis: evidence-based diagnostic evaluation of the upper motor neuron.
    Chan S; Kaufmann P; Shungu DC; Mitsumoto H
    Neuroimaging Clin N Am; 2003 May; 13(2):307-26. PubMed ID: 13677809
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Therapeutic vaccine for acute and chronic motor neuron diseases: implications for amyotrophic lateral sclerosis.
    Angelov DN; Waibel S; Guntinas-Lichius O; Lenzen M; Neiss WF; Tomov TL; Yoles E; Kipnis J; Schori H; Reuter A; Ludolph A; Schwartz M
    Proc Natl Acad Sci U S A; 2003 Apr; 100(8):4790-5. PubMed ID: 12668759
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Not a benign motor neuron disease: longitudinal imaging captures relentless motor connectome disintegration in primary lateral sclerosis.
    Tahedl M; Tan EL; Shing SLH; Chipika RH; Siah WF; Hengeveld JC; Doherty MA; McLaughlin RL; Hardiman O; Finegan E; Bede P
    Eur J Neurol; 2023 May; 30(5):1232-1245. PubMed ID: 36739888
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinicopathological features of primary lateral sclerosis are different from amyotrophic lateral sclerosis.
    Hudson AJ; Kiernan JA; Munoz DG; Pringle CE; Brown WF; Ebers GC
    Brain Res Bull; 1993; 30(3-4):359-64. PubMed ID: 8457884
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Motor neuron diseases : Clinical and genetic differential diagnostics].
    Regensburger M; Weidner N; Kohl Z
    Nervenarzt; 2018 Jun; 89(6):658-665. PubMed ID: 29767817
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Corticomotoneuronal connections in primary lateral sclerosis (PLS).
    Weber M; Stewart H; Hirota N; Eisen A
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2002 Dec; 3(4):190-8. PubMed ID: 12710508
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of the amyotrophic lateral sclerosis and motor neurone disease community in health-care resourcing.
    Levvy G
    Int J Clin Pract Suppl; 1998 Apr; 93():14-7. PubMed ID: 9691245
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human-induced pluripotent stem cells pave the road for a better understanding of motor neuron disease.
    Winner B; Marchetto MC; Winkler J; Gage FH
    Hum Mol Genet; 2014 Sep; 23(R1):R27-34. PubMed ID: 24821704
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.